“Efficacy and Safety of Roflumilast Foam 0.3% in Patients With Seborrheic Dermatitis in a Phase 3 Trial: Assessment of Pruritus”. SKIN The Journal of Cutaneous Medicine 7, no. 4 (July 17, 2023): s226. Accessed May 30, 2025. https://skin.dermsquared.com/skin/article/view/2193.